The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Bob Djavan

Department of Urology

VA University Hospital

New York University School of Medicine (NYU)

New York

USA

[email]@hotmail.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Urology, VA University Hospital, New York University School of Medicine (NYU), New York, USA. 2010 - 2011
  • New York University, Department of Urology, USA. 2010
  • Department of Urology, University of Vienna, Austria. 1999 - 2007
  • Department of Urology, University of Vienna, Wahringer Gurtel 18-20, 1090 Vienna, Austria. 2002 - 2007
  • Department of Urology, Prostate Disease Center, Ludwig Boltzmand Institute for Prostatic disease, University of Vienna, Austria. 2004

References

  1. An algorithm for medical management in male lower urinary tract symptoms. Djavan, B., Margreiter, M., Dianat, S.S. Curr. Opin. Urol (2011) [Pubmed]
  2. Prostate-specific antigen testing and prostate cancer screening. Djavan, B., Eckersberger, E., Finkelstein, J., Sadri, H., Taneja, S.S., Lepor, H. Prim. Care (2010) [Pubmed]
  3. Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Djavan, B., Handl, M.J., Dianat, S. Expert. Opin. Pharmacother (2010) [Pubmed]
  4. Biopsy standards for detection of prostate cancer. Djavan, B., Margreiter, M. World. J. Urol (2007) [Pubmed]
  5. Is the era of prostate-specific antigen over?. Djavan, B., Rocco, B., Stangelberger, A., De Cobelli, O., Marberger, M. BJU Int. (2007) [Pubmed]
  6. European Study of Radical Prostatectomy: time trends in Europe, 1993-2005. Djavan, B., Ravery, V., Rocco, B., Zlotta, A., Brausi, M., Margreiter, M., Hammerer, P., Kaisary, A., Anagnostou, T., Romics, I., Dobronski, P., De Cobelli, O., Marberger, M. BJU Int. (2007) [Pubmed]
  7. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study. Djavan, B., Fong, Y.K., Ravery, V., Remzi, M., Horninger, W., Susani, M., Kreuzer, S., Boccon-Gibod, L., Bartsch, G., Marberger, M. Eur. Urol. (2005) [Pubmed]
  8. Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia. Djavan, B., Milani, S., Fong, Y.K. Expert. Opin. Pharmacother (2005) [Pubmed]
  9. Progression delay in men with mild symptoms of bladder outlet obstruction: a comparative study of phytotherapy and watchful waiting. Djavan, B., Fong, Y.K., Chaudry, A., Reissigl, A., Anagnostou, T., Bagheri, F., Waldert, M., Fajkovic, H., Marihart, S., Harik, M., Spaller, S., Remzi, M. World. J. Urol (2005) [Pubmed]
  10. Chemotherapeutic prevention studies of prostate cancer. Djavan, B., Zlotta, A., Schulman, C., Teillac, P., Iversen, P., Boccon Gibod, L., Bartsch, G., Marberger, M. J. Urol. (2004) [Pubmed]
  11. Benign prostatic hyperplasia progression and its impact on treatment. Djavan, B., Waldert, M., Ghawidel, C., Marberger, M. Curr. Opin. Urol (2004) [Pubmed]
  12. Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years. Djavan, B., Fong, Y.K., Harik, M., Milani, S., Reissigl, A., Chaudry, A., Anagnostou, T., Bagheri, F., Waldert, M., Kreuzer, S., Fajkovic, H., Marberger, M. Urology (2004) [Pubmed]
  13. PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium. Djavan, B., Moul, J.W., Zlotta, A., Remzi, M., Ravery, V. Eur. Urol. (2003) [Pubmed]
  14. Heat versus drugs in the treatment of benign prostatic hyperplasia. Djavan, B., Seitz, C., Marberger, M. BJU Int. (2003) [Pubmed]
  15. When to biopsy and when to stop biopsying. Djavan, B., Remzi, M., Marberger, M. Urol. Clin. North Am. (2003) [Pubmed]
  16. Novel artificial neural network for early detection of prostate cancer. Djavan, B., Remzi, M., Zlotta, A., Seitz, C., Snow, P., Marberger, M. J. Clin. Oncol. (2002) [Pubmed]
  17. The urologist view of BPH progression: results of an international survey. Djavan, B., Nickel, J.C., de la Rosette, J., Abrams, P. Eur. Urol. (2002) [Pubmed]
  18. Guidelines on benign prostatic hyperplasia: where do we stand in the new millennium?. Djavan, B. Curr. Urol. Rep (2002) [Pubmed]
  19. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial. Djavan, B., Remzi, M., Zlotta, A.R., Ravery, V., Hammerer, P., Reissigl, A., Dobronski, P., Kaisary, A., Marberger, M. Urology (2002) [Pubmed]
  20. The pathophysiology of benign prostatic hyperplasia. Djavan, B., Remzi, M., Erne, B., Marberger, M. Drugs. Today (2002) [Pubmed]
  21. Minimally invasive procedures as an alternative to medical management for lower urinary tract symptoms of benign prostatic hyperplasia. Djavan, B., Marberger, M. Curr. Opin. Urol (2001) [Pubmed]
  22. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study. Djavan, B., Mazal, P., Zlotta, A., Wammack, R., Ravery, V., Remzi, M., Susani, M., Borkowski, A., Hruby, S., Boccon-Gibod, L., Schulman, C.C., Marberger, M. Prostate (2001) [Pubmed]
  23. Insulin-like growth factors and prostate cancer. Djavan, B., Waldert, M., Seitz, C., Marberger, M. World. J. Urol (2001) [Pubmed]
  24. Transurethral microwave thermotherapy: an alternative to medical management in patients with benign prostatic hyperplasia?. Djavan, B., Marberger, M. J. Endourol. (2000) [Pubmed]
  25. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Djavan, B., Marberger, M. Eur. Urol. (1999) [Pubmed]
  26. Elastin gene expression in benign prostatic hyperplasia. Djavan, B., Lin, V., Seitz, C., Kramer, G., Kaplan, P., Richier, J., Marberger, M., McConnell, J.D. Prostate (1999) [Pubmed]
 
WikiGenes - Universities